sthrn labs is launching soon. Browse the catalog, review our COAs, and inquire to order.
Selank
Selank is a synthetic heptapeptide analogue of the immunomodulatory peptide tuftsin. It is studied for its potential anxiolytic and nootropic properties in preclinical research. For research use only.
Compound information
What is Selank?
Stability information
Research highlights
GABAergic modulation
Research on this tuftsin-derived heptapeptide and GABA-receptor system activity.
Anxiolytic mechanism
Studies exploring non-sedating anxiety-pathway modulation.
BDNF expression
Investigating brain-derived neurotrophic factor and neuroplasticity signaling.
Enkephalin metabolism
Mechanistic work on enkephalin-degrading enzyme inhibition.
Sources & references
Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia
Selank administration affects the expression of some genes involved in GABAergic neurotransmission
All citations link directly to primary literature. sthrn labs does not reproduce, excerpt, or summarize article content.
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
